14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $18.05 $25.50 Thursday, 2nd May 2024 PHVS stock ended at $23.53. This is 4.23% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 8.56% from a day low at $23.49 to a day high of $25.50.
90 days $18.05 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
Aug 22, 2023 $20.11 $20.47 $19.50 $20.00 38 826
Aug 21, 2023 $18.28 $20.47 $18.28 $20.00 34 013
Aug 18, 2023 $18.75 $19.21 $17.83 $18.28 27 097
Aug 17, 2023 $20.00 $20.56 $18.55 $19.32 36 934
Aug 16, 2023 $21.17 $21.48 $20.00 $20.10 78 588
Aug 15, 2023 $21.00 $26.86 $19.50 $20.00 247 482
Aug 14, 2023 $18.20 $19.84 $18.02 $18.42 36 764
Aug 11, 2023 $17.99 $18.60 $17.95 $18.56 15 664
Aug 10, 2023 $17.39 $18.30 $16.52 $18.30 60 335
Aug 09, 2023 $17.86 $18.46 $17.00 $17.25 246 919
Aug 08, 2023 $17.78 $18.55 $17.41 $18.08 37 052
Aug 07, 2023 $18.34 $18.71 $17.11 $17.52 53 472
Aug 04, 2023 $17.70 $19.08 $17.12 $18.82 56 658
Aug 03, 2023 $17.38 $17.87 $17.20 $17.71 28 114
Aug 02, 2023 $17.01 $17.44 $16.90 $17.03 23 049
Aug 01, 2023 $17.10 $17.98 $16.85 $17.05 103 648
Jul 31, 2023 $16.39 $17.47 $16.39 $17.00 136 784
Jul 28, 2023 $16.54 $17.33 $16.54 $16.91 58 621
Jul 27, 2023 $17.88 $18.71 $16.10 $16.76 52 792
Jul 26, 2023 $18.47 $18.47 $15.60 $17.27 72 279
Jul 25, 2023 $16.26 $18.50 $16.26 $18.50 51 088
Jul 24, 2023 $16.40 $16.81 $15.96 $16.26 50 073
Jul 21, 2023 $16.30 $16.75 $16.20 $16.53 12 942
Jul 20, 2023 $15.95 $16.50 $15.73 $15.93 30 219
Jul 19, 2023 $14.35 $17.55 $14.35 $15.77 94 107
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT